Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Diseases of the Thyroid

  Free Subscription


Articles published in J Endocrinol Invest

Retrieve available abstracts of 234 articles:
HTML format



Single Articles


    March 2024
  1. MENOTTI S, Mura C, Raia S, Bergianti L, et al
    Overt hypothyroidism in pregnancy and language development in offspring: is there an association?
    J Endocrinol Invest. 2024 Mar 18. doi: 10.1007/s40618-024-02317.
    PubMed     Abstract available


  2. WANG C, Wang Z, Fu L, Du J, et al
    CircNRCAM up-regulates NRCAM to promote papillary thyroid carcinoma progression.
    J Endocrinol Invest. 2024 Mar 14. doi: 10.1007/s40618-023-02241.
    PubMed     Abstract available


  3. D'ANIELLO F, Amodeo ME, Grossi A, Ubertini G, et al
    Thyroiditis and COVID-19: focus on pediatric age. A narrative review.
    J Endocrinol Invest. 2024 Mar 8. doi: 10.1007/s40618-024-02331.
    PubMed     Abstract available


  4. SPARANO C, Puccioni M, Adornato V, Zago E, et al
    Improving the TIR3B oncological stratification: try to bridge the gap through a comprehensive presurgical algorithm.
    J Endocrinol Invest. 2024;47:633-643.
    PubMed     Abstract available


    February 2024
  5. ZHANG GQ, Xi C, Ju NT, Shen CT, et al
    Targeting glutamine metabolism exhibits anti-tumor effects in thyroid cancer.
    J Endocrinol Invest. 2024 Feb 22. doi: 10.1007/s40618-023-02294.
    PubMed     Abstract available


  6. BABAYID Y, Gokcay Canpolat A, Elhan AH, Ceyhan K, et al
    Should there be a paradigm shift for the evaluation of isthmic thyroid nodules?
    J Endocrinol Invest. 2024 Feb 16. doi: 10.1007/s40618-024-02313.
    PubMed     Abstract available


  7. LIU L, Cai S, Chen A, Dong Y, et al
    Long-term prognostic value of thyroid hormones in left ventricular noncompaction.
    J Endocrinol Invest. 2024 Feb 15. doi: 10.1007/s40618-024-02311.
    PubMed     Abstract available


  8. EVRANOS BO, Ince N, Atas H, Polat SB, et al
    Successful localisation of recurrent thyroid cancer using preoperative patent blue dye injection.
    J Endocrinol Invest. 2024 Feb 14. doi: 10.1007/s40618-024-02301.
    PubMed     Abstract available


  9. CENSI S, Carducci S, Zoppini G, Toffalini A, et al
    Calcitonin levels in autoimmune atrophic gastritis-related hypergastrinemia.
    J Endocrinol Invest. 2024;47:357-365.
    PubMed     Abstract available


    January 2024
  10. HE C, Li Y, Gan L, Lin Y, et al
    Notch signaling regulates Th17 cells differentiation through PI3K/AKT/mTORC1 pathway and involves in the thyroid injury of autoimmune thyroiditis.
    J Endocrinol Invest. 2024 Jan 29. doi: 10.1007/s40618-023-02293.
    PubMed     Abstract available


  11. KENARLI K, Bahcecioglu AB, Aksu OB, Gullu S, et al
    Are sonographic characteristics of Hashimoto's thyroiditis related with immunologic parameters? A cross-sectional study.
    J Endocrinol Invest. 2024 Jan 21. doi: 10.1007/s40618-023-02286.
    PubMed     Abstract available


  12. LOSA M, Albano L, Barzaghi LR, Bailo M, et al
    Gamma knife radiosurgery is effective in patients with thyrotropin-secreting pituitary adenomas.
    J Endocrinol Invest. 2024 Jan 20. doi: 10.1007/s40618-023-02291.
    PubMed     Abstract available


  13. TAGGI M, Capponi C, Bertani N, Saturno G, et al
    Role of thyroid stimulating hormone in the maintenance and functioning of the human corpus luteum.
    J Endocrinol Invest. 2024 Jan 8. doi: 10.1007/s40618-023-02269.
    PubMed     Abstract available


  14. COSENTINO G, Comi S, Maglionico MN, Marino M, et al
    A case of carotid cavernous fistula mimicking Graves' orbitopathy.
    J Endocrinol Invest. 2024;47:255-256.
    PubMed    


    December 2023
  15. LU DN, Zhang WC, Lin YZ, Jiang HY, et al
    Single-cell and bulk RNA sequencing reveal heterogeneity and diagnostic markers in papillary thyroid carcinoma lymph-node metastasis.
    J Endocrinol Invest. 2023 Dec 26. doi: 10.1007/s40618-023-02262.
    PubMed     Abstract available


  16. GONG Z, Xue L, Vlantis AC, van Hasselt CA, et al
    Brusatol attenuated proliferation and invasion induced by KRAS in differentiated thyroid cancer through inhibiting Nrf2.
    J Endocrinol Invest. 2023 Dec 7. doi: 10.1007/s40618-023-02248.
    PubMed     Abstract available


    November 2023
  17. PRETE A, Pieroni E, Marrama E, Bruschini L, et al
    Management of patients with extensive locally advanced thyroid cancer: results of multimodal treatments.
    J Endocrinol Invest. 2023 Nov 30. doi: 10.1007/s40618-023-02234.
    PubMed     Abstract available


  18. FELDT-RASMUSSEN U, Effraimidis G, Bliddal S, Klose M, et al
    Risks of suboptimal and excessive thyroid hormone replacement across ages.
    J Endocrinol Invest. 2023 Nov 28. doi: 10.1007/s40618-023-02229.
    PubMed     Abstract available


  19. BEDULEVA L, Sidorov A, Fomina K, Terentiev A, et al
    Experimental rat models for Hashimoto's thyroiditis.
    J Endocrinol Invest. 2023 Nov 27. doi: 10.1007/s40618-023-02240.
    PubMed     Abstract available


    October 2023
  20. LEI C, Qu M, Sun H, Huang J, et al
    Facial expression of patients with Graves' orbitopathy.
    J Endocrinol Invest. 2023;46:2055-2066.
    PubMed     Abstract available


  21. CAO J, Qi X, Wang N, Chen Y, et al
    Ceruloplasmin regulating fibrosis in orbital fibroblasts provides a novel therapeutic target for Graves' orbitopathy.
    J Endocrinol Invest. 2023;46:2005-2016.
    PubMed     Abstract available


    September 2023
  22. CAPPELLANI D, Bartalena L, Bogazzi F
    Short review: novel concepts in the approach to patients with amiodarone-induced thyrotoxicosis.
    J Endocrinol Invest. 2023 Sep 20. doi: 10.1007/s40618-023-02168.
    PubMed     Abstract available


  23. CROCE L, Ruggeri RM, Cappelli C, Virili C, et al
    Cardiovascular and metabolic comorbidities in patients with thyroid nodules: the impact of incidental diagnosis.
    J Endocrinol Invest. 2023 Sep 13. doi: 10.1007/s40618-023-02191.
    PubMed     Abstract available


    August 2023
  24. BESHARAT ZM, Trocchianesi S, Verrienti A, Ciampi R, et al
    Correction: Circulating miR‑26b‑5p and miR‑451a as diagnostic biomarkers in medullary thyroid carcinoma patients.
    J Endocrinol Invest. 2023 Aug 10. doi: 10.1007/s40618-023-02172.
    PubMed    


  25. ZHANG H, Xie H, Li L
    Association of radioactive iodine treatment in differentiated thyroid cancer and cardiovascular death: a large population-based study.
    J Endocrinol Invest. 2023 Aug 6. doi: 10.1007/s40618-023-02159.
    PubMed     Abstract available


  26. LANZOLLA G, Di Matteo L, Comi S, Cosentino G, et al
    Absence of a relationship between vitamin D and Graves' orbitopathy.
    J Endocrinol Invest. 2023;46:1717-1721.
    PubMed    


    July 2023
  27. JIANG C, Xu F, Yi D, Jiang B, et al
    Testosterone promotes the migration, invasion and EMT process of papillary thyroid carcinoma by up-regulating Tnnt1.
    J Endocrinol Invest. 2023 Jul 21. doi: 10.1007/s40618-023-02132.
    PubMed     Abstract available


  28. WUSIMAN D, Guo L, Li L, Zhang X, et al
    Clinicopathological and prognostic significance of PD-L1 and TIM-3 expression in medullary thyroid carcinoma: a retrospective immunohistochemistry study.
    J Endocrinol Invest. 2023 Jul 18. doi: 10.1007/s40618-023-02126.
    PubMed     Abstract available


  29. PELEWICZ-SOWA M, Miskiewicz P
    Dysthyroid optic neuropathy: emerging treatment strategies.
    J Endocrinol Invest. 2023;46:1305-1316.
    PubMed     Abstract available


    June 2023
  30. MA Q, Chen Z, Fang Y, Wei X, et al
    Development and validation of survival nomograms for patients with differentiated thyroid cancer with distant metastases: a SEER Program-based study.
    J Endocrinol Invest. 2023 Jun 9. doi: 10.1007/s40618-023-02129.
    PubMed     Abstract available


  31. BESHARAT ZM, Trocchianesi S, Verrienti A, Ciampi R, et al
    Circulating miR-26b-5p and miR-451a as diagnostic biomarkers in medullary thyroid carcinoma patients.
    J Endocrinol Invest. 2023 Jun 7. doi: 10.1007/s40618-023-02115.
    PubMed     Abstract available


    May 2023
  32. ASHRAFIAN H
    Goiter in the paintings by Rogier van der Weyden (1399-1464).
    J Endocrinol Invest. 2023 May 12. doi: 10.1007/s40618-023-02108.
    PubMed    


  33. ASHRAFIAN H
    Goiter, thyroid facial involvement and eye disease in the paintings of Jan Gossaert (c. 1478-1532).
    J Endocrinol Invest. 2023 May 6. doi: 10.1007/s40618-023-02104.
    PubMed    


  34. JIANG B, Wang C, Qu C, Jiang C, et al
    Primary human thyrocytes maintained the function of thyroid hormone production and secretion in vitro.
    J Endocrinol Invest. 2023 May 3. doi: 10.1007/s40618-023-02103.
    PubMed     Abstract available


  35. BIANUCCI R, Galassi FM, Donell ST, Nerlich AG, et al
    Goitre in a Fayum mummy portrait from Roman Egypt (120-140 CE).
    J Endocrinol Invest. 2023;46:1041-1042.
    PubMed    


    April 2023
  36. BERLINSKA A, Swiatkowska-Stodulska R
    Simple nontoxic goiter in the portrayal of Saints: a magnificent representation in one piece of art.
    J Endocrinol Invest. 2023 Apr 28. doi: 10.1007/s40618-023-02097.
    PubMed    


  37. DORIZZI RM, Spiazzi G, Rolli N, Maltoni P, et al
    Trimester-specific reference intervals for thyroid function parameters in pregnant Caucasian women using Roche platforms: a prospective study.
    J Endocrinol Invest. 2023 Apr 24. doi: 10.1007/s40618-023-02098.
    PubMed     Abstract available


  38. LORUSSO L, Minaldi E, Esposito G, Piaggi P, et al
    Radio-iodine refractory thyroid cancer patients: a tailored follow-up based on clinicopathological features.
    J Endocrinol Invest. 2023 Apr 21. doi: 10.1007/s40618-023-02076.
    PubMed     Abstract available


  39. RUGGERI RM, Spagnolo CC, Alibrandi A, Silvestris N, et al
    Predictors of thyroid adverse events during cancer immunotherapy: a real-life experience at a single center.
    J Endocrinol Invest. 2023 Apr 20. doi: 10.1007/s40618-023-02096.
    PubMed     Abstract available


  40. GRANI G, Lamartina L, Montesano T, Maranghi M, et al
    Ultrasound screening for thyroid nodules and cancer in individuals with family history of thyroid cancer: a micro-costing approach.
    J Endocrinol Invest. 2023 Apr 13. doi: 10.1007/s40618-023-02087.
    PubMed     Abstract available


  41. PERONA M, Ibanez IL, Thomasz L, Villaverde MS, et al
    Valproic acid radiosensitizes anaplastic thyroid cells through a decrease of the DNA damage repair capacity.
    J Endocrinol Invest. 2023 Apr 13. doi: 10.1007/s40618-023-02092.
    PubMed     Abstract available


  42. CALCATERRA V, Gazzarri A, De Silvestri A, Madia C, et al
    Thyroid function, sensitivity to thyroid hormones, and metabolic syndrome in euthyroid children and adolescents with Down syndrome.
    J Endocrinol Invest. 2023 Apr 11. doi: 10.1007/s40618-023-02086.
    PubMed     Abstract available


  43. PINTO S, Croce L, Carlier L, Cosson E, et al
    Thyroid dysfunction during gestation and gestational diabetes mellitus: a complex relationship.
    J Endocrinol Invest. 2023 Apr 7. doi: 10.1007/s40618-023-02079.
    PubMed     Abstract available


  44. SARIC MATUTINOVIC M, Kahaly GJ, Zarkovic M, Ciric J, et al
    The phenotype of Graves' orbitopathy is associated with thyrotropin receptor antibody levels.
    J Endocrinol Invest. 2023 Apr 5. doi: 10.1007/s40618-023-02085.
    PubMed     Abstract available


  45. SIGMAN B, Linder DF, Waller JL, Bollag WB, et al
    Hashimoto's thyroiditis and renal transplant rejection.
    J Endocrinol Invest. 2023 Apr 4. doi: 10.1007/s40618-023-02065.
    PubMed     Abstract available


  46. COSENTINO G, Comi S, Coco B, Marino M, et al
    Autoimmune hepatitis after high-dose intravenous glucocorticoids for Graves' orbitopathy.
    J Endocrinol Invest. 2023;46:849-850.
    PubMed    


  47. BETTERLE C, Furmaniak J, Sabbadin C, Scaroni C, et al
    Type 3 autoimmune polyglandular syndrome (APS-3) or type 3 multiple autoimmune syndrome (MAS-3): an expanding galaxy.
    J Endocrinol Invest. 2023;46:643-665.
    PubMed     Abstract available


  48. MODICA R, Benevento E, Colao A
    Endocrine-disrupting chemicals (EDCs) and cancer: new perspectives on an old relationship.
    J Endocrinol Invest. 2023;46:667-677.
    PubMed     Abstract available


  49. LI YY, Li SJ, Liu MC, Chen Z, et al
    B cells and tertiary lymphoid structures are associated with survival in papillary thyroid cancer.
    J Endocrinol Invest. 2023 Apr 1. doi: 10.1007/s40618-023-02072.
    PubMed     Abstract available


    March 2023
  50. PATTI L, Gay S, Musso L, Maltese C, et al
    Impact of microscopic extrathyroidal extension on differentiated thyroid cancer post-surgical risk of recurrence: a retrospective analysis.
    J Endocrinol Invest. 2023 Mar 28. doi: 10.1007/s40618-023-02070.
    PubMed     Abstract available


  51. BAGALA V, Sala A, Trevisan C, Okoye C, et al
    Clinical presentation and prognosis of COVID-19 in older adults with hypothyroidism: data from the GeroCovid observational study.
    J Endocrinol Invest. 2023 Mar 27:1-9. doi: 10.1007/s40618-023-02048.
    PubMed     Abstract available


  52. PECCE V, Sponziello M, Verrienti A, Grani G, et al
    The role of miR-139-5p in radioiodine-resistant thyroid cancer.
    J Endocrinol Invest. 2023 Mar 18. doi: 10.1007/s40618-023-02059.
    PubMed     Abstract available


  53. MONTI E, Gay S, Dono M, Giusti M, et al
    PD-L1 expression, BRAF and TERT mutation in a cohort of aggressive thyroid cancers: case series from a single-centre experience.
    J Endocrinol Invest. 2023 Mar 18. doi: 10.1007/s40618-023-02063.
    PubMed    


  54. FELICETTI F, Gatti F, Faraci D, Rosso D, et al
    Impact of allogeneic stem cell transplantation on thyroid function.
    J Endocrinol Invest. 2023 Mar 8. doi: 10.1007/s40618-023-02039.
    PubMed     Abstract available


  55. ABEILLON-DU PAYRAT J, Grunenwald S, Gall E, Ladsous M, et al
    Graves' orbitopathy post-SARS-CoV-2 vaccines: report on six patients.
    J Endocrinol Invest. 2023;46:617-627.
    PubMed     Abstract available


    February 2023
  56. BRANCATELLA A, Torregrossa L, Viola N, Sgro D, et al
    In Graves' disease, thyroid autoantibodies and ultrasound features correlate with distinctive histological features.
    J Endocrinol Invest. 2023 Feb 25. doi: 10.1007/s40618-023-02044.
    PubMed     Abstract available


  57. DI SESSA A, Cembalo Sambiase Sanseverino N, De Simone RF, Marrapodi MM, et al
    Association between non-alcoholic fatty liver disease and subclinical hypothyroidism in children with obesity.
    J Endocrinol Invest. 2023 Feb 24. doi: 10.1007/s40618-023-02041.
    PubMed     Abstract available


  58. ERBAS IM, Cakir MD, Yener AS, Demir K, et al
    Long-term follow-up results and treatment outcomes of children and adults with resistance to thyroid hormone alpha.
    J Endocrinol Invest. 2023 Feb 23. doi: 10.1007/s40618-023-02043.
    PubMed     Abstract available


  59. VALERIO L, Giani C, Matrone A, Pontillo-Contillo B, et al
    Adrenal insufficiency in thyroid cancer patients treated with tyrosine kinase inhibitors and detected by ACTH stimulation test.
    J Endocrinol Invest. 2023 Feb 21. doi: 10.1007/s40618-023-02025.
    PubMed     Abstract available


  60. LIU C, Hua L, Liu K, Xin Z, et al
    Impaired sensitivity to thyroid hormone correlates to osteoporosis and fractures in euthyroid individuals.
    J Endocrinol Invest. 2023 Feb 16. doi: 10.1007/s40618-023-02035.
    PubMed     Abstract available


  61. HAI YP, Lee ACH, Chen K, Kahaly GJ, et al
    Traditional Chinese medicine in thyroid-associated orbitopathy.
    J Endocrinol Invest. 2023 Feb 12. doi: 10.1007/s40618-023-02024.
    PubMed     Abstract available


  62. LEFRERE B, Libe R, Groussin L
    Keeping cards close to the chest: goiter in one of the oldest tarots.
    J Endocrinol Invest. 2023 Feb 8. doi: 10.1007/s40618-023-02019.
    PubMed    


  63. MACEROLA E, Poma AM, Vignali P, Proietti A, et al
    MicroRNA expression profiling of RAS-mutant thyroid tumors with follicular architecture: microRNA signatures to discriminate benign from malignant lesions.
    J Endocrinol Invest. 2023 Feb 7. doi: 10.1007/s40618-023-02023.
    PubMed     Abstract available


  64. LI Y, Luo B, Tong B, Xie Z, et al
    The role and molecular mechanism of gut microbiota in Graves' orbitopathy.
    J Endocrinol Invest. 2023;46:305-317.
    PubMed     Abstract available


  65. LI C, Dong X, Yuan Q, Xu G, et al
    Identification of novel characteristic biomarkers and immune infiltration profile for the anaplastic thyroid cancer via machine learning algorithms.
    J Endocrinol Invest. 2023 Feb 1. doi: 10.1007/s40618-023-02022.
    PubMed     Abstract available


    January 2023
  66. ASHRAFIAN H
    Goiter and thyroid eye sign in the Madonna and Child with Angels by Francesco del Cossa (c. 1430-1477).
    J Endocrinol Invest. 2023 Jan 14. doi: 10.1007/s40618-023-02012.
    PubMed    


  67. ASHRAFIAN H
    Differential diagnosis of a thyroid mass, Gottron's papules, Calcinosis Cutis and Ptosis on the Saint Mary Magdalen and two depictions of a Madonna and Baby by Bartolomeo Vivarini (1432-1499).
    J Endocrinol Invest. 2023 Jan 12. doi: 10.1007/s40618-023-02004.
    PubMed    


  68. TRIMARCHI F, Martino E
    Endemic goiter in two masterpieces by Piero della Francesca (c.1415-1492).
    J Endocrinol Invest. 2023 Jan 7. doi: 10.1007/s40618-023-02005.
    PubMed    


  69. CHEN Z, Su Y, Peng D, Wang W, et al
    Circ_0124055 promotes the progression of thyroid cancer cells through the miR-486-3p/MTA1 axis.
    J Endocrinol Invest. 2023 Jan 5. doi: 10.1007/s40618-022-01998.
    PubMed     Abstract available


  70. FIRAT SN, Kuskonmaz SM, Onder CE, Omma T, et al
    Sonographic evaluation of subclinical entheseal involvement in patients with hypoparathyroidism: a case control study.
    J Endocrinol Invest. 2023;46:133-139.
    PubMed     Abstract available


  71. CHAUDHARY S, Das L, Sharma N, Sachdeva N, et al
    Utility of myxedema score as a predictor of mortality in myxedema coma.
    J Endocrinol Invest. 2023;46:59-65.
    PubMed     Abstract available


  72. NERLICH AG, Galassi FM, Donell ST, Bianucci R, et al
    Early sixteenth century gargoyle figurine with evidence of massive multinodular hyper-vascularised goitre and superior vena cava syndrome.
    J Endocrinol Invest. 2023;46:201-202.
    PubMed    


    December 2022
  73. MAGRI F, Bellingeri C, De Maggio I, Croce L, et al
    A first-trimester serum TSH in the 4-10 mIU/L range is associated with obstetric complications in thyroid peroxidase antibody-negative women.
    J Endocrinol Invest. 2022 Dec 23. doi: 10.1007/s40618-022-01996.
    PubMed     Abstract available


  74. ZHENG G, Cai Y, Guo Y, Song F, et al
    The association between dietary selenium intake and Hashimoto's thyroiditis among US adults: National Health and Nutrition Examination Survey (NHANES), 2007-2012.
    J Endocrinol Invest. 2022 Dec 14. doi: 10.1007/s40618-022-01987.
    PubMed     Abstract available


  75. LEFRERE B, Libe R, Groussin L
    "The fool says in his heart, 'There is no God'": a fifteenth century portrait of a goitrous jester.
    J Endocrinol Invest. 2022 Dec 12. doi: 10.1007/s40618-022-01988.
    PubMed    


  76. SUN W, Wang Z, Xiang J, Qin Y, et al
    Newly proposed survival staging system for poorly differentiated thyroid cancer: a SEER-based study.
    J Endocrinol Invest. 2022 Dec 9. doi: 10.1007/s40618-022-01958.
    PubMed     Abstract available


    November 2022
  77. ABUDUWAILI M, Su A, Xing Z, Xia B, et al
    Clinical significance of extrathyroidal extension to major vessels in papillary thyroid carcinoma.
    J Endocrinol Invest. 2022 Nov 24. doi: 10.1007/s40618-022-01966.
    PubMed     Abstract available


  78. LI J, Mi L, Ran B, Sui C, et al
    Identification of potential diagnostic and prognostic biomarkers for papillary thyroid microcarcinoma (PTMC) based on TMT-labeled LC-MS/MS and machine learning.
    J Endocrinol Invest. 2022 Nov 23. doi: 10.1007/s40618-022-01960.
    PubMed     Abstract available


  79. WANG X, Zheng X, Zhu J, Li Z, et al
    A nomogram and risk classification system for predicting cancer-specific survival in tall cell variant of papillary thyroid cancer: a SEER-based study.
    J Endocrinol Invest. 2022 Nov 15. pii: 10.1007/s40618-022-01949.
    PubMed     Abstract available


  80. LANZOLLA G, Maglionico MN, Comi S, Menconi F, et al
    Sirolimus as a second-line treatment for Graves' orbitopathy.
    J Endocrinol Invest. 2022;45:2171-2180.
    PubMed     Abstract available


    October 2022
  81. SHU C, Wang S, Hu J, Xu M, et al
    CircNDST1 promotes papillary thyroid cancer progression via its interaction with CSNK2A1 to activate the PI3K-Akt pathway and epithelial-mesenchymal transition.
    J Endocrinol Invest. 2022 Oct 28. pii: 10.1007/s40618-022-01928.
    PubMed     Abstract available


  82. ZHANG H, Jiang J, He X, Zhou Q, et al
    Circ_0002111/miR-134-5p/FSTL1 signal axis regulates tumor progression and glycolytic metabolism in papillary thyroid carcinoma cells.
    J Endocrinol Invest. 2022 Oct 13. pii: 10.1007/s40618-022-01921.
    PubMed     Abstract available


  83. LI HG, Zhao LH, Liu JZ, Liu KP, et al
    Silencing circ_0000644 inhibits papillary thyroid cancer cell malignancy by combining with miR-671-5p to release the inhibition on ANXA2.
    J Endocrinol Invest. 2022 Oct 12. pii: 10.1007/s40618-022-01930.
    PubMed     Abstract available


    September 2022
  84. KHAMISI S, Lundqvist M, Rasmusson AJ, Engstrom BE, et al
    Vitamin D and bone metabolism in Graves' disease: a prospective study.
    J Endocrinol Invest. 2022 Sep 27. pii: 10.1007/s40618-022-01927.
    PubMed     Abstract available


  85. YE J, Feng JW, Wu WX, Qi GF, et al
    Microarray profiling identifies hsa_circ_0082003 as a novel tumor promoter for papillary thyroid carcinoma.
    J Endocrinol Invest. 2022 Sep 17. pii: 10.1007/s40618-022-01922.
    PubMed     Abstract available


  86. GENTILINI D, Muzza M, de Filippis T, Vigone MC, et al
    Stochastic epigenetic mutations as possible explanation for phenotypical discordance among twins with congenital hypothyroidism.
    J Endocrinol Invest. 2022 Sep 7. pii: 10.1007/s40618-022-01915.
    PubMed     Abstract available


  87. COLONNELLO E, Criniti A, Lorusso E, Curreli M, et al
    Thyroid hormones and platelet activation in COVID-19 patients.
    J Endocrinol Invest. 2022 Sep 5. pii: 10.1007/s40618-022-01896.
    PubMed     Abstract available


  88. VINTHER CJ, Poulsen LH, Nicolaisen P, Obling ML, et al
    Do bone turnover markers reflect changes in bone microarchitecture during treatment of patients with thyroid dysfunction?
    J Endocrinol Invest. 2022 Sep 5. pii: 10.1007/s40618-022-01907.
    PubMed     Abstract available


  89. RODIA R, Meloni PE, Mascia C, Balestrieri C, et al
    Direct-acting antivirals used in HCV-related liver disease do not affect thyroid function and autoimmunity.
    J Endocrinol Invest. 2022 Sep 1. pii: 10.1007/s40618-022-01909.
    PubMed     Abstract available


    August 2022
  90. LANZOLLA G, Puccinelli L, Giudetti M, Comi S, et al
    Anti-nuclear autoantibodies in Graves' disease and Graves' orbitopathy.
    J Endocrinol Invest. 2022 Aug 27. pii: 10.1007/s40618-022-01906.
    PubMed     Abstract available


  91. MONZANI ML, Piccinini F, Boselli G, Corleto R, et al
    Changes in quality of life after thyroidectomy in subjects with thyroid cancer in relation to the dose of levothyroxine.
    J Endocrinol Invest. 2022 Aug 21. pii: 10.1007/s40618-022-01903.
    PubMed     Abstract available


  92. KIRKIZLAR HO, Celik M
    Therapeutic plasma exchange in hyperthyroidism prior to surgery.
    J Endocrinol Invest. 2022 Aug 13. pii: 10.1007/s40618-022-01897.
    PubMed     Abstract available


  93. MAZZILLI R, Medenica S, Di Tommaso AM, Fabozzi G, et al
    The role of thyroid function in female and male infertility: a narrative review.
    J Endocrinol Invest. 2022 Aug 9. pii: 10.1007/s40618-022-01883.
    PubMed     Abstract available


  94. POZZILLI P, Villa Giovanni CF
    A beautiful image of the thyroid in an apparently healthy young boy.
    J Endocrinol Invest. 2022 Aug 9. pii: 10.1007/s40618-022-01850.
    PubMed    


  95. AMOUZEGAR A, Dehghani M, Abdi H, Mehran L, et al
    Natural history of subclinical hypothyroidism and prognostic factors for the development of overt hypothyroidism: Tehran Thyroid Study (TTS).
    J Endocrinol Invest. 2022 Aug 4. pii: 10.1007/s40618-022-01876.
    PubMed     Abstract available


  96. ALMAS SP, Werneck FZ, Coelho EF, Teixeira PFS, et al
    Endurance training improves heart rate on-kinetics in women with subclinical hypothyroidism: a preliminary study.
    J Endocrinol Invest. 2022 Aug 2. pii: 10.1007/s40618-022-01882.
    PubMed     Abstract available


  97. BARTALENA L, Marcocci C, Tanda ML, Marino M, et al
    Reply to Letter to the Editor by Dr. Terry J. Smith regarding teprotumumab and ototoxicity.
    J Endocrinol Invest. 2022;45:1603-1604.
    PubMed    


    July 2022
  98. TANG Y, Meng X, Yu X, Shang H, et al
    Retraction Note to: Inhibition of microRNA8755p promotes radioiodine uptake in poorly differentiated thyroid carcinoma cells by upregulating sodium-iodide symporter.
    J Endocrinol Invest. 2022 Jul 14. pii: 10.1007/s40618-022-01852.
    PubMed    


  99. LUI DTW, Lee CH, Chow WS, Lee ACH, et al
    Development of a prediction score (ThyroCOVID) for identifying abnormal thyroid function in COVID-19 patients.
    J Endocrinol Invest. 2022 Jul 13. pii: 10.1007/s40618-022-01854.
    PubMed     Abstract available


  100. COPERCHINI F, Greco A, Denegri M, Ripepi FA, et al
    Vitamin D and interferon-gamma co-operate to increase the ACE-2 receptor expression in primary cultures of human thyroid cells.
    J Endocrinol Invest. 2022 Jul 12. pii: 10.1007/s40618-022-01857.
    PubMed     Abstract available


  101. RUGGERI RM, Giovanellla L, Campenni A
    SARS-CoV-2 vaccine may trigger thyroid autoimmunity: real-life experience and review of the literature.
    J Endocrinol Invest. 2022 Jul 12. pii: 10.1007/s40618-022-01863.
    PubMed     Abstract available


  102. FENG JW, Wu WX, Qi GF, Hong LZ, et al
    Nomograms based on sonographic and clinicopathological characteristics to predict lateral lymph node metastasis in classic papillary thyroid carcinoma.
    J Endocrinol Invest. 2022 Jul 9. pii: 10.1007/s40618-022-01825.
    PubMed     Abstract available


  103. SENA LM, Riva MA
    An ugly man with a bi-lobar goiter. "Christ and the Adulteress" (c. 1506) by Nicolo de Barbari.
    J Endocrinol Invest. 2022 Jul 8. pii: 10.1007/s40618-022-01851.
    PubMed    


  104. TETI C, Nazzari E, Graziani G, Bagnasco M, et al
    Subacute thyroiditis after SARS-CoV2 vaccine: possible relapse after boosting.
    J Endocrinol Invest. 2022 Jul 5. pii: 10.1007/s40618-022-01856.
    PubMed    


  105. FIERABRACCI P, Basolo A, Scartabelli G, Bechi Genzano S, et al
    Possible added value of thyroglobulin antibody (TgAb) testing in the evaluation of thyroidal status of subjects with overweight or obesity.
    J Endocrinol Invest. 2022 Jul 4. pii: 10.1007/s40618-022-01839.
    PubMed     Abstract available


  106. BARTALENA L, Marino M, Marcocci C, Tanda ML, et al
    Teprotumumab for Graves' orbitopathy and ototoxicity: moving problems from eyes to ears?
    J Endocrinol Invest. 2022;45:1455-1457.
    PubMed    


    June 2022
  107. RODRIGUEZ DE VERA GOMEZ P, Garcia-Gonzalez JJ, Rave-Garcia R, Lopez Ruiz R, et al
    Graves' disease induced by Alemtuzumab in relapsing-remitting multiple sclerosis patients: an observational study in a reference center.
    J Endocrinol Invest. 2022 Jun 20. pii: 10.1007/s40618-022-01832.
    PubMed     Abstract available


  108. VAROTTO E, Galassi FM, Lippi D, Bianucci R, et al
    Depiction of goitre in an Etruscan Genucilia Terracotta plate (late 5th-early 4th BCE).
    J Endocrinol Invest. 2022;45:1273-1274.
    PubMed    


    May 2022
  109. SAADAT N, Azizi F, Abdi H, Amouzegar A, et al
    Treatment of post-radioactive iodine relapse of hyperthyroidism: comparison of long-term methimazole and radioactive iodine treatment.
    J Endocrinol Invest. 2022 May 24. pii: 10.1007/s40618-022-01823.
    PubMed     Abstract available


  110. OKOYE C, Niccolai F, Rogani S, Lemmi B, et al
    Is non-thyroidal illness syndrome (NTIS) a clinical predictor of COVID-19 mortality in critically ill oldest old patients?
    J Endocrinol Invest. 2022 May 11. pii: 10.1007/s40618-022-01806.
    PubMed    


    April 2022
  111. AMIRI M, Nazarpour S, Ramezani Tehrani F, Sheidaei A, et al
    The targeted high-risk case-finding approach versus universal screening for thyroid dysfunction during pregnancy: thyroid-stimulating hormone (TSH) and/or thyroid peroxidase antibody (TPOAb) test?
    J Endocrinol Invest. 2022 Apr 2. pii: 10.1007/s40618-021-01738.
    PubMed     Abstract available


  112. SPARANO C, Zago E, Morettini A, Nozzoli C, et al
    Euthyroid sick syndrome as an early surrogate marker of poor outcome in mild SARS-CoV-2 disease.
    J Endocrinol Invest. 2022;45:837-847.
    PubMed     Abstract available


  113. PAPAVRAMIDIS TS, Anagnostis P, Pliakos I, Tzikos G, et al
    The impact of age on quality of life and frailty outcomes after parathyroidectomy in patients with primary hyperparathyroidism.
    J Endocrinol Invest. 2022;45:797-802.
    PubMed     Abstract available


    March 2022
  114. JAFARZADEH A, Nemati M, Jafarzadeh S, Nozari P, et al
    Thyroid dysfunction following vaccination with COVID-19 vaccines: a basic review of the preliminary evidence.
    J Endocrinol Invest. 2022 Mar 26. pii: 10.1007/s40618-022-01786.
    PubMed     Abstract available


  115. ZARKOVIC M, Perros P, Ciric J, Beleslin B, et al
    Health care access of thyroid disease patients in Serbia during the COVID-19 pandemic.
    J Endocrinol Invest. 2022 Mar 24. pii: 10.1007/s40618-022-01787.
    PubMed     Abstract available


  116. CHEN Y, Dong B, Jiang Z, Cai Q, et al
    SuperSonic shear imaging for the differentiation between benign and malignant thyroid nodules: a meta-analysis.
    J Endocrinol Invest. 2022 Mar 1. pii: 10.1007/s40618-022-01765.
    PubMed     Abstract available


  117. ROTONDO DOTTORE G, Torregrossa L, Lanzolla G, Mariotti S, et al
    Role of the mononuclear cell infiltrate in Graves' orbitopathy (GO): results of a large cohort study.
    J Endocrinol Invest. 2022;45:563-572.
    PubMed     Abstract available


  118. MAZONI L, Matrone A, Apicella M, Saponaro F, et al
    Renal complications and quality of life in postsurgical hypoparathyroidism: a case-control study.
    J Endocrinol Invest. 2022;45:573-582.
    PubMed     Abstract available


    February 2022
  119. TONI R, Barbaro F, Di Conza G, Trimarchi F, et al
    Nodular goiter and laryngeal anatomic variant in two portraits of the hellenistic dramatist Menander.
    J Endocrinol Invest. 2022 Feb 27. pii: 10.1007/s40618-022-01772.
    PubMed    


  120. YORULMAZ G, Sahin Tekin M
    SARS-CoV-2 vaccine-associated subacute thyroiditis.
    J Endocrinol Invest. 2022 Feb 19. pii: 10.1007/s40618-022-01767.
    PubMed     Abstract available


  121. PENG CC, Pearce EN
    An update on thyroid disorders in the postpartum period.
    J Endocrinol Invest. 2022 Feb 18. pii: 10.1007/s40618-022-01762.
    PubMed     Abstract available


  122. TIENFORTI D, Di Giulio F, Spagnolo L, Castellini C, et al
    Chronic urticaria and thyroid autoimmunity: a meta-analysis of case-control studies.
    J Endocrinol Invest. 2022 Feb 18. pii: 10.1007/s40618-022-01761.
    PubMed     Abstract available


  123. DIONIGI G, Dionigi R
    Goiter in a fresco by i Fiammenghini, 1615 (Abbey of Santa Maria di Rovegnano, Chiaravalle, Italy).
    J Endocrinol Invest. 2022 Feb 16. pii: 10.1007/s40618-022-01763.
    PubMed     Abstract available


  124. FREILINGER A, Kaserer K, Zettinig G, Pruidze P, et al
    Ultrasound for the detection of the pyramidal lobe of the thyroid gland.
    J Endocrinol Invest. 2022 Feb 14. pii: 10.1007/s40618-022-01748.
    PubMed     Abstract available


  125. AFRASHTEH S, Fararouei M, Parad MT, Mirahmadizadeh A, et al
    Sleep quality, stress and thyroid cancer: a case-control study.
    J Endocrinol Invest. 2022 Feb 2. pii: 10.1007/s40618-022-01751.
    PubMed     Abstract available


  126. AMOUZEGAR A, Pearce EN, Mehran L, Lazarus J, et al
    TPO antibody in euthyroid pregnant women and cognitive ability in the offspring: a focused review.
    J Endocrinol Invest. 2022;45:425-431.
    PubMed     Abstract available


    January 2022
  127. IPPOLITO S, Gallo D, Rossini A, Patera B, et al
    SARS-CoV-2 vaccine-associated subacute thyroiditis: insights from a systematic review.
    J Endocrinol Invest. 2022 Jan 29. pii: 10.1007/s40618-022-01747.
    PubMed     Abstract available


  128. SPARANO C, Maggi M, Petrone L
    Response to Letter to the Editor from Lui et al.: 'Euthyroid sick syndrome as an early surrogate marker of poor outcome in mild SARS-CoV-2 disease': prognostic significance of non-thyroidal illness syndrome in the whole spectrum of COVID-19 severity.
    J Endocrinol Invest. 2022 Jan 28. pii: 10.1007/s40618-021-01733.
    PubMed    


  129. AZIZI F, Abdi H, Mehran L, Amouzegar A, et al
    Appropriate duration of antithyroid drug treatment as a predictor for relapse of Graves' disease: a systematic scoping review.
    J Endocrinol Invest. 2022 Jan 28. pii: 10.1007/s40618-021-01730.
    PubMed     Abstract available


  130. CAPEZZONE M, Tosti-Balducci M, Morabito EM, Caldarelli GP, et al
    Silent thyroiditis following vaccination against COVID-19: report of two cases.
    J Endocrinol Invest. 2022 Jan 16. pii: 10.1007/s40618-021-01725.
    PubMed     Abstract available


  131. LUI DTW, Lee CH, Lam KSL
    Letter to the Editor: 'Euthyroid sick syndrome as an early surrogate marker of poor outcome in mild SARSCoV2 disease'-prognostic significance of non-thyroidal illness syndrome across the whole spectrum of COVID-19 severity.
    J Endocrinol Invest. 2022 Jan 13. pii: 10.1007/s40618-021-01732.
    PubMed    


  132. BAHCECIOGLU AB, Karahan ZC, Aydogan BI, Kalkan IA, et al
    Subacute thyroiditis during the COVID-19 pandemic: a prospective study.
    J Endocrinol Invest. 2022 Jan 13. pii: 10.1007/s40618-021-01718.
    PubMed     Abstract available


  133. PLA PERIS B, Merchante Alfaro AA, Maravall Royo FJ, Abellan Galiana P, et al
    Thyrotoxicosis following SARS-COV-2 vaccination: a case series and discussion.
    J Endocrinol Invest. 2022 Jan 11. pii: 10.1007/s40618-022-01739.
    PubMed     Abstract available


  134. TANDA ML, Ippolito S, Gallo D, Baj A, et al
    SARS-CoV-2 detection in primary thyroid sarcoma: coincidence or interaction?
    J Endocrinol Invest. 2022 Jan 5. pii: 10.1007/s40618-021-01722.
    PubMed     Abstract available


    December 2021
  135. ZHU Y, Yang S, He X
    Prognostic evaluation models for primary thyroid lymphoma, based on the SEER database and an external validation cohort.
    J Endocrinol Invest. 2021 Dec 4. pii: 10.1007/s40618-021-01712.
    PubMed     Abstract available


  136. LI Z, Xu J, Guan H, Lai J, et al
    Circ_0059354 aggravates the progression of papillary thyroid carcinoma by elevating ARFGEF1 through sponging miR-766-3p.
    J Endocrinol Invest. 2021 Dec 2. pii: 10.1007/s40618-021-01713.
    PubMed     Abstract available


  137. LANZOLLA G, Menconi F, Nicoli F, Posarelli C, et al
    Beneficial effect of low-dose radioiodine ablation for Graves' orbitopathy: results of a retrospective study.
    J Endocrinol Invest. 2021;44:2575-2579.
    PubMed     Abstract available


    November 2021
  138. PUJOL A, Gomez LA, Gallegos C, Nicolau J, et al
    Thyroid as a target of adjuvant autoimmunity/inflammatory syndrome due to mRNA-based SARS-CoV2 vaccination: from Graves' disease to silent thyroiditis.
    J Endocrinol Invest. 2021 Nov 18. pii: 10.1007/s40618-021-01707.
    PubMed     Abstract available


  139. ACAR S, Gursoy S, Arslan G, Nalbantoglu O, et al
    Screening of 23 candidate genes by next-generation sequencing of patients with permanent congenital hypothyroidism: novel variants in TG, TSHR, DUOX2, FOXE1, and SLC26A7.
    J Endocrinol Invest. 2021 Nov 15. pii: 10.1007/s40618-021-01706.
    PubMed     Abstract available


  140. GAWANDI S, Jothivel K, Kulkarni S
    Identification of a novel mutation in thyroxine-binding globulin (TBG) gene associated with TBG-deficiency and its effect on the thyroid function.
    J Endocrinol Invest. 2021 Nov 10. pii: 10.1007/s40618-021-01697.
    PubMed     Abstract available


  141. SIOMKAJLO M, Mizera L, Szymczak D, Kolackov K, et al
    Effect of systemic steroid therapy in Graves' orbitopathy on regulatory T cells and Th17/Treg ratio.
    J Endocrinol Invest. 2021;44:2475-2484.
    PubMed     Abstract available


  142. TANDA ML, Trimarchi F
    Graves' orbitopathy in Natalie Frank's oeuvre.
    J Endocrinol Invest. 2021;44:2533-2534.
    PubMed    


  143. MACIEL J, Dias D, Cavaco D, Donato S, et al
    Growth hormone deficiency and other endocrinopathies after childhood brain tumors: results from a close follow-up in a cohort of 242 patients.
    J Endocrinol Invest. 2021;44:2367-2374.
    PubMed     Abstract available


    October 2021
  144. CVEK M, Punda A, Brekalo M, Plosnic M, et al
    Presence or severity of Hashimoto's thyroiditis does not influence basal calcitonin levels: observations from CROHT biobank.
    J Endocrinol Invest. 2021 Oct 6. pii: 10.1007/s40618-021-01685.
    PubMed     Abstract available


  145. DELSHAD H, Raeisi A, Abdollahi Z, Tohidi M, et al
    Iodine supplementation for pregnant women: a cross-sectional national interventional study.
    J Endocrinol Invest. 2021;44:2307-2314.
    PubMed     Abstract available


    September 2021
  146. DAS L, Bhadada SK, Sood A
    Post-COVID-vaccine autoimmune/inflammatory syndrome in response to adjuvants (ASIA syndrome) manifesting as subacute thyroiditis.
    J Endocrinol Invest. 2021 Sep 28. pii: 10.1007/s40618-021-01681.
    PubMed    


  147. DIONIGI G, Dionigi R
    Goiter in a Fresco by Giovanni Luigi Valesio (1611, Church of Saints Eusebio and Vittore, Peglio, Como).
    J Endocrinol Invest. 2021 Sep 21. pii: 10.1007/s40618-021-01678.
    PubMed     Abstract available


  148. WEI X, Min Y, Feng Y, He D, et al
    Development and validation of an individualized nomogram for predicting the high-volume (> 5) central lymph node metastasis in papillary thyroid microcarcinoma.
    J Endocrinol Invest. 2021 Sep 7. pii: 10.1007/s40618-021-01675.
    PubMed     Abstract available


  149. DIONIGI G, Dionigi R
    Goiter in a fresco by simone peterzano, master of caravaggio (1578-1582, Garegnano Charterhouse, Milan).
    J Endocrinol Invest. 2021 Sep 3. pii: 10.1007/s40618-021-01670.
    PubMed     Abstract available


  150. PALADINO ME, Riva MA
    The sponge-bearer suffers from goiter: "The Passion of Christ" (c. 1530) by Fermo Stella.
    J Endocrinol Invest. 2021 Sep 2. pii: 10.1007/s40618-021-01667.
    PubMed     Abstract available


  151. JAKSIC J, Pandzic Jaksic V
    Mystery of love, goiter and death in flu pandemic.
    J Endocrinol Invest. 2021 Sep 2. pii: 10.1007/s40618-021-01668.
    PubMed     Abstract available


    August 2021
  152. MARTINO E, Macri L, Trimarchi F
    Goiter in the models of Pre-Raphaelite Brotherhood.
    J Endocrinol Invest. 2021 Aug 24. pii: 10.1007/s40618-021-01658.
    PubMed    


  153. NEAG EJ, Smith TJ
    2021 update on thyroid-associated ophthalmopathy.
    J Endocrinol Invest. 2021 Aug 20. pii: 10.1007/s40618-021-01663.
    PubMed     Abstract available


  154. AGRETTI P, De Marco G, Ferrarini E, Di Cosmo C, et al
    Gene expression profile in functioning and non-functioning nodules of autonomous multinodular goiter from an area of iodine deficiency: unexpected common characteristics between the two entities.
    J Endocrinol Invest. 2021 Aug 17. pii: 10.1007/s40618-021-01660.
    PubMed     Abstract available


  155. BASOLO A, Poma AM, Giannini R, Ceccarini G, et al
    Histological pattern and gene expression profiling of thyroid tissue in subjects with obesity.
    J Endocrinol Invest. 2021 Aug 15. pii: 10.1007/s40618-021-01662.
    PubMed     Abstract available


  156. MELE C, Pagano L, Franciotta D, Caputo M, et al
    Thyroid function in the subacute phase of traumatic brain injury: a potential predictor of post-traumatic neurological and functional outcomes.
    J Endocrinol Invest. 2021 Aug 5. pii: 10.1007/s40618-021-01656.
    PubMed     Abstract available


  157. MARZOCCHI C, Capezzone M, Sagnella A, Cartocci A, et al
    Pregnancy-associated plasma protein A mRNA expression as a marker for differentiated thyroid cancer: results from a "surgical" and a "cytological" series.
    J Endocrinol Invest. 2021 Aug 4. pii: 10.1007/s40618-021-01655.
    PubMed     Abstract available


  158. ZETTINIG G, Krebs M
    Two further cases of Graves' disease following SARS-Cov-2 vaccination.
    J Endocrinol Invest. 2021 Aug 3. pii: 10.1007/s40618-021-01650.
    PubMed    


  159. TRIMARCHI F, Martino E, Bartalena L
    Comics' representation of Graves' orbitopathy, by Emil Ferris.
    J Endocrinol Invest. 2021;44:1799-1800.
    PubMed    


    July 2021
  160. SARIC MATUTINOVIC M, Diana T, Nedeljkovic Beleslin B, Ciric J, et al
    Clinical value of functional thyrotropin receptor antibodies in Serbian patients with Graves' orbitopathy.
    J Endocrinol Invest. 2021 Jul 29. pii: 10.1007/s40618-021-01652.
    PubMed     Abstract available


  161. CALCATERRA V, Biganzoli G, Dilillo D, Mannarino S, et al
    Non-thyroidal illness syndrome and SARS-CoV-2-associated multisystem inflammatory syndrome in children.
    J Endocrinol Invest. 2021 Jul 26. pii: 10.1007/s40618-021-01647.
    PubMed     Abstract available


  162. DIANA T, Ponto KA, Kahaly GJ
    Correction to: Thyrotropin receptor antibodies and Graves' orbitopathy.
    J Endocrinol Invest. 2021 Jul 24. pii: 10.1007/s40618-021-01632.
    PubMed    


  163. LORUSSO L, Pieruzzi L, Gabriele M, Nisi M, et al
    Osteonecrosis of the jaw: a rare but possible side effect in thyroid cancer patients treated with tyrosine-kinase inhibitors and bisphosphonates.
    J Endocrinol Invest. 2021 Jul 21. pii: 10.1007/s40618-021-01634.
    PubMed     Abstract available


  164. YANG S, Xu X
    Bronze masks of mysterious Sanxingdui: oldest record of Graves' disease?
    J Endocrinol Invest. 2021 Jul 21. pii: 10.1007/s40618-021-01643.
    PubMed    


  165. RODIA R, Pani F, Caocci G, La Nasa G, et al
    Thyroid autoimmunity and hypothyroidism are associated with deep molecular response in patients with chronic myeloid leukemia on tyrosine kinase inhibitors.
    J Endocrinol Invest. 2021 Jul 20. pii: 10.1007/s40618-021-01613.
    PubMed     Abstract available


  166. SCAPPATICCIO L, Maiorino MI, Iorio S, Camponovo C, et al
    Thyroid surgery during the COVID-19 pandemic: results from a systematic review.
    J Endocrinol Invest. 2021 Jul 19. pii: 10.1007/s40618-021-01641.
    PubMed     Abstract available


  167. RIVA MA, Cambioli L
    A damned soul with goiter. "The life of Christ" (c. 1480) by Giovanni Martino Spanzotti.
    J Endocrinol Invest. 2021 Jul 16. pii: 10.1007/s40618-021-01636.
    PubMed     Abstract available


  168. ASHRAFIAN H
    Differential diagnosis of a thyroid mass, facial malar rash and ptosis on the flora in the primavera by Sandro Botticelli (1445-1510).
    J Endocrinol Invest. 2021 Jul 9. pii: 10.1007/s40618-021-01623.
    PubMed     Abstract available


  169. LACROIX C, Potard G, Thuillier P, Le Pennec R, et al
    Use of the parathyroid hormone assay at H6 post thyroidectomy: an early predictor of hypocalcemia.
    J Endocrinol Invest. 2021 Jul 3. pii: 10.1007/s40618-021-01601.
    PubMed     Abstract available


  170. CANNARELLA R, Condorelli RA, Barbagallo F, Aversa A, et al
    TSH lowering effects of metformin: a possible mechanism of action.
    J Endocrinol Invest. 2021;44:1547-1550.
    PubMed     Abstract available


    June 2021
  171. WANG Y, Ye H, Yang Y, Li J, et al
    microRNA-181a promotes the oncogene S100A2 and enhances papillary thyroid carcinoma growth by mediating the expression of histone demethylase KDM5C.
    J Endocrinol Invest. 2021 Jun 18. pii: 10.1007/s40618-021-01606.
    PubMed     Abstract available


  172. BAUER M, Whybrow PC
    Role of thyroid hormone therapy in depressive disorders.
    J Endocrinol Invest. 2021 Jun 15. pii: 10.1007/s40618-021-01600.
    PubMed     Abstract available


  173. POZZILLI P, Nicolai L
    Cosimo I de Medici and his Merseburg triad of Graves' disease.
    J Endocrinol Invest. 2021 Jun 10. pii: 10.1007/s40618-021-01610.
    PubMed    


  174. BALDELLI R, Nicastri E, Petrosillo N, Marchioni L, et al
    Thyroid dysfunction in COVID-19 patients.
    J Endocrinol Invest. 2021 Jun 8. pii: 10.1007/s40618-021-01599.
    PubMed     Abstract available


  175. MATRONE A, Prete A, Nervo A, Ragni A, et al
    Correction to: Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer.
    J Endocrinol Invest. 2021 Jun 5. pii: 10.1007/s40618-021-01592.
    PubMed    


    May 2021
  176. CORONA G, Croce L, Sparano C, Petrone L, et al
    Thyroid and heart, a clinically relevant relationship.
    J Endocrinol Invest. 2021 May 25. pii: 10.1007/s40618-021-01590.
    PubMed     Abstract available


  177. TRIMARCHI F, Martino E
    "The Salutation of Beatrice" by Dante Gabriel Rossetti: it was not Beatrice who had goiter but her model.
    J Endocrinol Invest. 2021 May 12. pii: 10.1007/s40618-021-01588.
    PubMed    


  178. MARINI TJ, Weiss SL, Gupta A, Zhao YT, et al
    Testing telediagnostic thyroid ultrasound in Peru: a new horizon in expanding access to imaging in rural and underserved areas.
    J Endocrinol Invest. 2021 May 10. pii: 10.1007/s40618-021-01584.
    PubMed     Abstract available


  179. LANZOLLA G, Marcocci C, Marino M
    Graves' disease and Graves' orbitopathy following COVID-19.
    J Endocrinol Invest. 2021 May 8. pii: 10.1007/s40618-021-01576.
    PubMed    


    April 2021
  180. RIVA MA, Belingheri M
    Dante and the goiter: a little-known medieval anecdote.
    J Endocrinol Invest. 2021 Apr 24. pii: 10.1007/s40618-021-01582.
    PubMed    


  181. SWAN KZ, Nielsen VE, Bonnema SJ
    Evaluation of thyroid nodules by shear wave elastography: a review of current knowledge.
    J Endocrinol Invest. 2021 Apr 16. pii: 10.1007/s40618-021-01570.
    PubMed     Abstract available


  182. MARINA M, Zatelli MC, Goldoni M, Del Rio P, et al
    Combination of ultrasound and molecular testing in malignancy risk estimate of Bethesda category IV thyroid nodules: results from a single-institution prospective study.
    J Endocrinol Invest. 2021 Apr 16. pii: 10.1007/s40618-021-01571.
    PubMed     Abstract available


  183. BIANUCCI R, Galassi FM, Donell ST, Nerlich AG, et al
    Nodular goiter in Pontormo's "Epifania Benintendi" (ca. 1520).
    J Endocrinol Invest. 2021 Apr 9. pii: 10.1007/s40618-021-01560.
    PubMed    


    March 2021
  184. RIIS KR, Frolich JS, Hegedus L, Negro R, et al
    Use of thyroid hormones in hypothyroid and euthyroid patients: A 2020 THESIS questionnaire survey of members of the Danish Endocrine Society.
    J Endocrinol Invest. 2021 Mar 28. pii: 10.1007/s40618-021-01555.
    PubMed     Abstract available


  185. LISCO G, De Tullio A, Jirillo E, Giagulli VA, et al
    Thyroid and COVID-19: a review on pathophysiological, clinical and organizational aspects.
    J Endocrinol Invest. 2021 Mar 25. pii: 10.1007/s40618-021-01554.
    PubMed     Abstract available


  186. SOUSA BECA, Silva BC, de Oliveira Guidotti T, Pires MC, et al
    Trabecular bone score in women with differentiated thyroid cancer on long-term TSH-suppressive therapy.
    J Endocrinol Invest. 2021 Mar 17. pii: 10.1007/s40618-021-01537.
    PubMed     Abstract available


  187. RUGGERI RM, Trimarchi F
    Iodine nutrition optimization: are there risks for thyroid autoimmunity?
    J Endocrinol Invest. 2021 Mar 8. pii: 10.1007/s40618-021-01548.
    PubMed     Abstract available


  188. MANCINO G, Miro C, Di Cicco E, Dentice M, et al
    Thyroid hormone action in epidermal development and homeostasis and its implications in the pathophysiology of the skin.
    J Endocrinol Invest. 2021 Mar 8. pii: 10.1007/s40618-020-01492.
    PubMed     Abstract available


  189. WU SC, Chi SY, Rau CS, Kuo PJ, et al
    Identification of circulating biomarkers for differentiating patients with papillary thyroid cancers from benign thyroid tumors.
    J Endocrinol Invest. 2021 Mar 1. pii: 10.1007/s40618-021-01543.
    PubMed     Abstract available


  190. DOLMAN PJ
    Dysthyroid optic neuropathy: evaluation and management.
    J Endocrinol Invest. 2021;44:421-429.
    PubMed     Abstract available


  191. NICOLI F, Lanzolla G, Mantuano M, Ionni I, et al
    Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves' orbitopathy.
    J Endocrinol Invest. 2021;44:581-585.
    PubMed     Abstract available


  192. LI HX, Zhao XH, Song Y, Mu BK, et al
    Changes in ocular biomechanics after treatment for active Graves' orbitopathy.
    J Endocrinol Invest. 2021;44:453-458.
    PubMed     Abstract available


  193. TRIMARCHI F, Martino E, Bartalena L
    The Virgin Mary with a small goiter breastfeeding the Child.
    J Endocrinol Invest. 2021;44:641-642.
    PubMed    


    February 2021
  194. GAN X, Guo M, Chen Z, Li Y, et al
    Development and validation of a three-immune-related gene signature prognostic risk model in papillary thyroid carcinoma.
    J Endocrinol Invest. 2021 Feb 23. pii: 10.1007/s40618-021-01514.
    PubMed     Abstract available


  195. MATRONE A, Prete A, Nervo A, Ragni A, et al
    Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer.
    J Endocrinol Invest. 2021 Feb 17. pii: 10.1007/s40618-020-01491.
    PubMed     Abstract available


  196. CRESCENZI A, Palermo A, Trimboli P
    Cancer prevalence in the subcategories of the indeterminate class III (AUS/FLUS) of the Bethesda system for thyroid cytology: a meta-analysis.
    J Endocrinol Invest. 2021 Feb 15. pii: 10.1007/s40618-021-01526.
    PubMed     Abstract available


  197. FENG Y, Min Y, Chen H, Xiang K, et al
    Construction and validation of a nomogram for predicting cervical lymph node metastasis in classic papillary thyroid carcinoma.
    J Endocrinol Invest. 2021 Feb 14. pii: 10.1007/s40618-021-01524.
    PubMed     Abstract available


  198. LUONGO C, Morra R, Gambale C, Porcelli T, et al
    Higher baseline TSH levels predict early hypothyroidism during cancer immunotherapy.
    J Endocrinol Invest. 2021 Feb 12. pii: 10.1007/s40618-021-01508.
    PubMed     Abstract available


  199. CAPEZZONE M, Maino F, Sagnella A, Campanile M, et al
    Clinical features of pediatric familial non-medullary thyroid cancer (FNMTC).
    J Endocrinol Invest. 2021 Feb 12. pii: 10.1007/s40618-021-01520.
    PubMed    


  200. MOURA MM, Cabrera RA, Esteves S, Cavaco BM, et al
    Correlation of molecular data with histopathological and clinical features in a series of 66 patients with medullary thyroid carcinoma.
    J Endocrinol Invest. 2021 Feb 11. pii: 10.1007/s40618-020-01456.
    PubMed     Abstract available


  201. CROCE L, Gangemi D, Ancona G, Liboa F, et al
    The cytokine storm and thyroid hormone changes in COVID-19.
    J Endocrinol Invest. 2021 Feb 9. pii: 10.1007/s40618-021-01506.
    PubMed     Abstract available


  202. ZHAO M, Yang F, Sang C, Yan C, et al
    BGL3 inhibits papillary thyroid carcinoma progression via regulating PTEN stability.
    J Endocrinol Invest. 2021 Feb 4. pii: 10.1007/s40618-021-01519.
    PubMed     Abstract available


  203. MA P, Chen P, Gao J, Guo H, et al
    Association of MICA gene polymorphisms with thionamide-induced agranulocytosis.
    J Endocrinol Invest. 2021;44:363-369.
    PubMed     Abstract available


    January 2021
  204. KHAMISI S, Lundqvist M, Emadi P, Almby K, et al
    Serum thyroglobulin is associated with orbitopathy in Graves' disease.
    J Endocrinol Invest. 2021 Jan 29. pii: 10.1007/s40618-021-01505.
    PubMed     Abstract available


  205. MATTOO S, Agarwal A, Mayilvaganan S, Mishra P, et al
    Role of postoperative intact serum PTH as an early predictor of severe post-thyroidectomy hypocalcemia: a prospective study.
    J Endocrinol Invest. 2021 Jan 27. pii: 10.1007/s40618-021-01511.
    PubMed     Abstract available


  206. CHEN J, Wang W, Guo Z, Huang S, et al
    Associations between gut microbiota and thyroidal function status in Chinese patients with Graves' disease.
    J Endocrinol Invest. 2021 Jan 22. pii: 10.1007/s40618-021-01507.
    PubMed     Abstract available


  207. DAL MASO L, Panato C, De Paoli A, Mattioli V, et al
    Trends in thyroid function testing, neck ultrasound, thyroid fine needle aspiration, and thyroidectomies in North-eastern Italy.
    J Endocrinol Invest. 2021 Jan 18. pii: 10.1007/s40618-020-01475.
    PubMed     Abstract available


  208. DALLARI V, Gazzini L, Sacchetto A
    Was Tiepolo's wife affected by Graves' disease?
    J Endocrinol Invest. 2021 Jan 2. pii: 10.1007/s40618-020-01487.
    PubMed     Abstract available


  209. HU X, Chen S, Xie C, Li Z, et al
    DPP4 gene silencing inhibits proliferation and epithelial-mesenchymal transition of papillary thyroid carcinoma cells through suppression of the MAPK pathway.
    J Endocrinol Invest. 2021 Jan 2. pii: 10.1007/s40618-020-01455.
    PubMed     Abstract available


  210. CAPPAGLI V, Moriconi D, Bonadio AG, Giannese D, et al
    Proteinuria is a late-onset adverse event in patients treated with cabozantinib.
    J Endocrinol Invest. 2021;44:95-103.
    PubMed     Abstract available


    December 2020
  211. BRILLI L, Danielli R, Campanile M, Secchi C, et al
    Baseline serum TSH levels predict the absence of thyroid dysfunction in cancer patients treated with immunotherapy.
    J Endocrinol Invest. 2020 Dec 26. pii: 10.1007/s40618-020-01480.
    PubMed     Abstract available


  212. IPPOLITO S, Cusini C, Lasalvia P, Gianfagna F, et al
    Change in newly diagnosed Graves' disease phenotype between the twentieth and the twenty-first centuries: meta-analysis and meta-regression.
    J Endocrinol Invest. 2020 Dec 21. pii: 10.1007/s40618-020-01479.
    PubMed     Abstract available


  213. WEETMAN AP
    An update on the pathogenesis of Hashimoto's thyroiditis.
    J Endocrinol Invest. 2020 Dec 17. pii: 10.1007/s40618-020-01477.
    PubMed     Abstract available


  214. FLIERS E, Boelen A
    An update on non-thyroidal illness syndrome.
    J Endocrinol Invest. 2020 Dec 15. pii: 10.1007/s40618-020-01482.
    PubMed     Abstract available


  215. COPERCHINI F, Croce L, Pignatti P, Ricci G, et al
    The new generation PFAS C6O4 does not produce adverse effects on thyroid cells in vitro.
    J Endocrinol Invest. 2020 Dec 14. pii: 10.1007/s40618-020-01466.
    PubMed     Abstract available


    November 2020
  216. NISHIKAWA Y, Suzuki C, Takahashi Y, Sawano T, et al
    No significant association between stable iodine intake and thyroid dysfunction in children after the Fukushima Nuclear Disaster: an observational study.
    J Endocrinol Invest. 2020 Nov 18. pii: 10.1007/s40618-020-01454.
    PubMed     Abstract available


  217. KYRGIOS I, Giza S, Fragou A, Tzimagiorgis G, et al
    DNA hypermethylation of PTPN22 gene promoter in children and adolescents with Hashimoto thyroiditis.
    J Endocrinol Invest. 2020 Nov 16. pii: 10.1007/s40618-020-01463.
    PubMed     Abstract available


  218. ZENG Y, He H, Wang X, Zhang M, et al
    Climate and air pollution exposure are associated with thyroid function parameters: a retrospective cross-sectional study.
    J Endocrinol Invest. 2020 Nov 7. pii: 10.1007/s40618-020-01461.
    PubMed     Abstract available


  219. KOUATCHEU SD, Marko J, Tamura D, Khan SG, et al
    Thyroid nodules in xeroderma pigmentosum patients: a feature of premature aging.
    J Endocrinol Invest. 2020 Nov 5. pii: 10.1007/s40618-020-01451.
    PubMed     Abstract available


  220. GAO W, Guo W, Guo Y, Shi M, et al
    Thyroid hormone concentrations in severely or critically ill patients with COVID-19.
    J Endocrinol Invest. 2020 Nov 2. pii: 10.1007/s40618-020-01460.
    PubMed     Abstract available


    October 2020
  221. SPAGGIARI G, Setti M, Tagliavini S, Roli L, et al
    The hypothalamic-pituitary-adrenal and -thyroid axes activation lasting one year after an earthquake swarm: results from a big data analysis.
    J Endocrinol Invest. 2020 Oct 29. pii: 10.1007/s40618-020-01457.
    PubMed     Abstract available


  222. GUARNOTTA V, Pillitteri G, Gambino G, Radellini S, et al
    Levothyroxine and insulin requirement in autoimmune polyglandular type 3 syndrome: a real-life study.
    J Endocrinol Invest. 2020 Oct 24. pii: 10.1007/s40618-020-01421.
    PubMed     Abstract available


  223. BOCALE R, Barini A, D'Amore A, Boscherin M, et al
    Thyroid hormones modulate irisin concentrations in patients with recently onset hypothyroidism following total thyroidectomy.
    J Endocrinol Invest. 2020 Oct 14. pii: 10.1007/s40618-020-01432.
    PubMed     Abstract available


  224. CAPEZZONE M, Robenshtok E, Cantara S, Castagna MG, et al
    Familial non-medullary thyroid cancer: a critical review.
    J Endocrinol Invest. 2020 Oct 6. pii: 10.1007/s40618-020-01435.
    PubMed     Abstract available


  225. JIMENEZ-BLANCO S, Pla-Peris B, Marazuela M
    COVID-19: a cause of recurrent Graves' hyperthyroidism?
    J Endocrinol Invest. 2020 Oct 6. pii: 10.1007/s40618-020-01440.
    PubMed    


  226. ROTONDI M, Coperchini F, Ricci G, Denegri M, et al
    Detection of SARS-COV-2 receptor ACE-2 mRNA in thyroid cells: a clue for COVID-19-related subacute thyroiditis.
    J Endocrinol Invest. 2020 Oct 6. pii: 10.1007/s40618-020-01436.
    PubMed     Abstract available


  227. PIRAS C, Pibiri M, Leoni VP, Balsamo A, et al
    Analysis of metabolomics profile in hypothyroid patients before and after thyroid hormone replacement.
    J Endocrinol Invest. 2020 Oct 6. pii: 10.1007/s40618-020-01434.
    PubMed     Abstract available


    September 2020
  228. DUNTAS LH
    Block-and-replace vs. titration antithyroid drug regimen for Graves' hyperthyroidism: two is not always better than one.
    J Endocrinol Invest. 2020 Sep 30. pii: 10.1007/s40618-020-01431.
    PubMed    


    July 2020
  229. POZZILLI P, Lazzeri D
    Our Lady of Carmel and Saints of Pietro Novelli (1603-1647).
    J Endocrinol Invest. 2020;43:1045-1046.
    PubMed    


    June 2020
  230. OGURA-OCHI K, Itoshima K, Kamada Y, Otsuka F, et al
    Macromolecules detected in highly increased serum luteinizing hormone.
    J Endocrinol Invest. 2020;43:865-866.
    PubMed    


  231. LEE ACH, Riedl M, Frommer L, Diana T, et al
    Systemic safety analysis of mycophenolate in Graves' orbitopathy.
    J Endocrinol Invest. 2020;43:767-777.
    PubMed     Abstract available


    April 2020
  232. MARINO M, Ionni I, Lanzolla G, Sframeli A, et al
    Orbital diseases mimicking graves' orbitopathy: a long-standing challenge in differential diagnosis.
    J Endocrinol Invest. 2020;43:401-411.
    PubMed     Abstract available


    March 2020
  233. PRESOTTO EM, Rastrelli G, Desideri I, Scotti V, et al
    Endocrine toxicity in cancer patients treated with nivolumab or pembrolizumab: results of a large multicentre study.
    J Endocrinol Invest. 2020;43:337-345.
    PubMed     Abstract available


    February 2020
  234. HAI YP, Lee ACH, Frommer L, Diana T, et al
    Immunohistochemical analysis of human orbital tissue in Graves' orbitopathy.
    J Endocrinol Invest. 2020;43:123-137.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diseases of the Thyroid is free of charge.